Introduction
Waldenström's macroglobulinemia (WM) is a chronic lymphoproliferative disorder which produces monoclonal immunoglobulin (Ig) M. WM is characterized by bone marrow infiltration by small lymphoid cells, plasmacytoid cells, and has been classified as lymphoplasmacytic lymphoma (LPL) by the World Health Organization (WHO) Classification (1) . WM/LPL is rarely complicated by other types of B cell malignancies and its prognosis is poor (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) .
Recent discussion has focused on whether or not two different B cell malignancies can originate from the same clone. Here, we report a case of multiple brain tumors of diffuse large B cell lymphoma (DLBL) occurring in a patient with WM/LPL. The difference in clonality from WM/LPL of the brain tumors was proven by means of polymerase chain reaction (PCR) and the sequence of immunoglobulin heavy chain (IgH) complementarity determining region III (CDR III).
Case Report
A 75-year-old man consulted our hospital in September 2001 because of general fatigue. The results of physical examination were unremarkable. Hematological and blood chemical laboratory data showed that hemoglobin was 9.6 mg/dl, total protein 9.7 g/dl with 3.5 g/dl of albumin, and IgM 4,740 mg/dl. Serum protein immunoelectrophoresis detected the presence of IgM-lambda gammopathy, while urine immunoelectrophoresis did not show any Bence-Jones protein. Bone marrow biopsy demonstrated nodular infiltration by small lymphoid cells and plasmacytoid cells (Fig. 1 12 /l, hemoglobin of 9.9 g/dl, platelets of 337×10 9 /l, total protein of 8.1 g/dl with 3.1 g/dl of albumin, and IgM of 4,120 mg/dl. The cerebrospinal fluid (CSF) contained 35 large lymphoma cells per cubic millimeter, 190 mg/dl of total protein, and 25 mg/dl of IgM. Cranial computed tomography (CT) scan showed multiple abnormally high and low density areas in the left frontal lobe, right basal ganglia and right cerebellar hemisphere. A cranial magnetic resonance imaging (MRI) scan demonstrated high intensity regions in the T2-weighted sequence in the same areas. These lesions were strongly enhanced by gadoliniumdiethylenetriaminepenta-acetic-acid (Gd-DTPA) (Fig. 2 , A-C). Chest and abdominal CT scan findings were normal. A 67 Ga-citrate scintigram revealed no abnormal accumulations. A stereotactic biopsy was performed on the left frontal lobe of the cerebrum. The biopsy specimen showed diffuse infiltration to the cerebral parenchyma by large lymphoma cells with an oval nucleus (Fig. 1C) . Immunohistochemical examination showed that all lymphoma cells stained positively for CD20, 30% of lymphoma cells for IgM, and 70% of lymphoma cells for lambda light chain. Immunohistochemical staining by IgG, IgA and kappa light chain was negative. The brain tumors were diagnosed as DLBL. Whole-brain irradiation therapy (RT) with 30 Gy was started on February 25, and consisted of 10 fractions given over 2 weeks. Intrathecal therapy with methotrexate (15 mg) and prednisolone (10 mg) was administered on February 25 and March 5. RT resulted in a reduction in the lymphoma cell count in CSF from 142 to 4 cells per cubic millimeter. A Gd-DTPA enhanced MRI scan 3 weeks after RT showed no abnormally enhanced region (Fig. 2D) .
In the middle of March, the patient developed pneumocystis carinii pneumonia. Although the pneumonia went into remission as a result of methylprednisolone pulse therapy and oral sulfamethoxazole-trimenthoprim, the cyclophosphamide and intrathecal therapy was stopped. Early in April, right hemiparesis was seen for the first time. Chest CT and MRI scan showed a right parathoracic vertebral tumor, which had infiltrated the thoracic spinal cord, as well as the presence of right pleural effusion (Fig.  3) . A specimen obtained with transcutaneous biopsy from the tumor showed infiltration by small, atypical lymphoid cells. Immunohistochemical staining showed that all of these cells were positive for CD20 and 70-80% of them for IgM and lambda light chain (Fig. 1, D-F To determine the clonal relationship between bone marrow, brain tumors and paravertebral tumor, we examined the IgH CDR III of paraffin-embedded sections by means of PCR analysis. DNA extraction and PCR were performed as previously described by Trainor et al (13) and by Wan et al (14) . For both PCR rounds Fr3A (the third framework) primer (5´-ACACGGC(C/T)(G/C)TGTATTACTCT-3´) was used as the sense primer. Two different JH primers, LJH (5´-TGAGGAGACGGTGACC-3´) and VLJH (5´-GTGACCA GGGT(A/G/C/T)CCTTGGCCCCAG-3´) were used as the respective anti-sense primers in the first and second round. The PCR products were electrophoresed on a 10% polyacrylamide gel and stained with ethidium bromide. We obtained the same PCR products around 60 bp and 80 bp from bone marrow and paravertebral tumor, but the product of brain tumors showed a different band around 75 bp (Fig.  4A) . To determine the clonal relationship between bone marrow, paravertebral tumor and brain tumors in more detail, we examined the DNA sequence of all the PCR products. The reamplified PCR products were purified and subcloned with a GENECLEAN II Kit (BIO 101, Vista, CA) and a TA Cloning Kit (Invitrogen, Carlsbad, CA). These products were sequenced with a BigDye Terminator vl.1 Cycle Sequence Kit (Applied Biosystems, Foster City, CA) and analyzed on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). We obtained two different PCR products (81 bp and 64 bp) from the bone marrow and paravertebral tumor, and one PCR product (76 bp) from the brain tumor. The DNA sequence proved that the clonality of the brain tumor was independent (Fig. 4B ).
Discussion
The case reported here was characterized by multiple brain tumors of DLBL co-occurring with WM/LPL, and the difference in the origin of DLBL and WM/LPL was demonstrated by PCR and DNA sequence analysis.
WM/LPL is considered to be a chronic lymphoproliferative disorder which produces monoclonal IgM, which makes the blood circulation sluggish and causes hyperviscosity syndrome. WM/LPL is classified as a low-grade malignant lymphoma, and the median survival of patients with WM/LPL is 5 years (3). Older age (>65 years), male sex, marked or remarkable lymphadenopathy, severe anemia (Hb <10g/dl), hypoalbuminemia (Alb <3.5g/dl), and severe bone marrow infiltration (>50%) have been reported as poor prognostic factors for WM/LPL (2, 15, 16) , and many of these were observed in the present case.
In 1936 about DLBL co-occurring with WM/LPL are that DLBL is a therapy-related (alkylating agent) secondary malignancy, and that there is a spontaneous association of DLBL with WM/LPL in a susceptible host (6, 8) . 
